Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008.

ABSTRACT: Although hemophilia has a potentially high economic impact, published estimates of health care costs for Americans with hemophilia are sparse and non-specific as to the non-bleeding complications of the disease. The objective of this study is to estimate average annual health care expenditures for people with hemophilia covered by employer-sponsored insurance, stratified according to the influence of age, type of hemophilia [A (factor VIII deficiency) versus B (factor IX)], presence of neutralizing alloantibody inhibitors and exposure to blood-borne viral infections. Data from the MarketScan Commercial and Medicare Research Databases were used for the period 2002-2008 to identify cases of hemophilia and to estimate mean and median medical expenditures during 2008. A total of 1,164 males wi

SUBMITTER: Guh S 

PROVIDER: S-EPMC4530317 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature